Taken together, the data suggest that lncNB1, RPL35, and E2F1 regulate DEPDC1B expression in human neuroblastoma tissues, and that high levels of lncNB1, DEPDC1B, RPL35, and E2F1 expression in tumor tissues predict poor prognosis in neuroblastoma patients. Here, RPL35 is linked to neoplasm.